- Markets
- Healthcare
- SYSCHEM
SYSCHEM
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Syschem (India) Approves Fundraising Via Convertible Warrants
Dec 24 (Reuters) - Syschem (India) Ltd SYCH.BO:
SYSCHEM (INDIA) LTD - BOARD APPROVES FUNDRAISING VIA CONVERTIBLE WARRANTS
SYSCHEM (INDIA) LTD - ISSUANCE OF 16.7 MILLION CONVERTIBLE WARRANTS AT 49 RUPEES EACH
Source text: ID:nBSE1xmb22
Further company coverage: SYCH.BO
(([email protected];))
Dec 24 (Reuters) - Syschem (India) Ltd SYCH.BO:
SYSCHEM (INDIA) LTD - BOARD APPROVES FUNDRAISING VIA CONVERTIBLE WARRANTS
SYSCHEM (INDIA) LTD - ISSUANCE OF 16.7 MILLION CONVERTIBLE WARRANTS AT 49 RUPEES EACH
Source text: ID:nBSE1xmb22
Further company coverage: SYCH.BO
(([email protected];))
Syschem India jumps after fund raise plan
** Shares of Syschem (India) SYCH.BO rise as much as 15.6% to 55 rupees, hitting their highest since May 2024
** Active pharmaceutical ingredient maker to consider raising funds via issue of equity or warrants on Dec. 24
** SYCH eyes best day since Jan. 2024; on track to snap two-day losing run
** Stock up ~8% so far this year, on track for fifth straight year of gains
** Peer Bharat Parenterals BATP.BO surged ~102% YTD
(Reporting by Dimpal Gulwani in Bengaluru)
** Shares of Syschem (India) SYCH.BO rise as much as 15.6% to 55 rupees, hitting their highest since May 2024
** Active pharmaceutical ingredient maker to consider raising funds via issue of equity or warrants on Dec. 24
** SYCH eyes best day since Jan. 2024; on track to snap two-day losing run
** Stock up ~8% so far this year, on track for fifth straight year of gains
** Peer Bharat Parenterals BATP.BO surged ~102% YTD
(Reporting by Dimpal Gulwani in Bengaluru)
Syschem (India) Board To Consider Fund-Raising
Dec 19 (Reuters) - Syschem (India) Ltd SYCH.BO:
BOARD TO CONSIDER FUND-RAISING THROUGH EQUITY/WARRANTS ISSUANCE
Source text: ID:nBSE6JMMJX
Further company coverage: SYCH.BO
(([email protected];))
Dec 19 (Reuters) - Syschem (India) Ltd SYCH.BO:
BOARD TO CONSIDER FUND-RAISING THROUGH EQUITY/WARRANTS ISSUANCE
Source text: ID:nBSE6JMMJX
Further company coverage: SYCH.BO
(([email protected];))
Syschem (India) Received Demand Notice Demanding Payment Under Solvency And Bankruptcy Code, 2016
June 14 (Reuters) - Syschem (India) Ltd SYCH.BO:
SYSCHEM (INDIA) LTD - RECEIVED DEMAND NOTICE DEMANDING PAYMENT UNDER SOLVENCY AND BANKRUPTCY CODE, 2016
SYSCHEM (INDIA) LTD - TOTAL AMOUNT CLAIM AT 106 MILLION RUPEES
Source text for Eikon: ID:nBSE4hnq22
Further company coverage: SYCH.BO
(([email protected];))
June 14 (Reuters) - Syschem (India) Ltd SYCH.BO:
SYSCHEM (INDIA) LTD - RECEIVED DEMAND NOTICE DEMANDING PAYMENT UNDER SOLVENCY AND BANKRUPTCY CODE, 2016
SYSCHEM (INDIA) LTD - TOTAL AMOUNT CLAIM AT 106 MILLION RUPEES
Source text for Eikon: ID:nBSE4hnq22
Further company coverage: SYCH.BO
(([email protected];))
Syschem (India) Received Sales Order From Its Customers Towards Supply Of Products Manufactured By Co
Aug 21 (Reuters) - Syschem (India) Ltd SYCH.BO:
RECEIVED SALES ORDER FROM ITS CUSTOMERS TOWARDS SUPPLY OF PRODUCTS MANUFACTURED BY CO
Source text for Eikon: ID:nBSE9FKVrS
Further company coverage: SYCH.BO
(([email protected];))
Aug 21 (Reuters) - Syschem (India) Ltd SYCH.BO:
RECEIVED SALES ORDER FROM ITS CUSTOMERS TOWARDS SUPPLY OF PRODUCTS MANUFACTURED BY CO
Source text for Eikon: ID:nBSE9FKVrS
Further company coverage: SYCH.BO
(([email protected];))
Syschem (India) Gets Sales Order Worth 30.6 Million Rupees
Aug 18 (Reuters) - Syschem (India) Ltd SYCH.BO:
GOT SALES ORDER WORTH 30.6 MILLION RUPEES
Source text for Eikon: ID:nBSE579c8W
Further company coverage: SYCH.BO
(([email protected];))
Aug 18 (Reuters) - Syschem (India) Ltd SYCH.BO:
GOT SALES ORDER WORTH 30.6 MILLION RUPEES
Source text for Eikon: ID:nBSE579c8W
Further company coverage: SYCH.BO
(([email protected];))
Syschem (India)Received Sales Order Worth 5.8 Million Rupees
Aug 16 (Reuters) - Syschem (India) Ltd SYCH.BO:
RECEIVED SALES ORDER WORTH 5.8 MILLION RUPEES
Source text for Eikon: ID:nBSEbpS9QL
Further company coverage: SYCH.BO
(([email protected];))
Aug 16 (Reuters) - Syschem (India) Ltd SYCH.BO:
RECEIVED SALES ORDER WORTH 5.8 MILLION RUPEES
Source text for Eikon: ID:nBSEbpS9QL
Further company coverage: SYCH.BO
(([email protected];))
Syschem (India) Approved Issue Of Shares Worth 319 Million Rupees Via Rights Issue
July 4 (Reuters) - Syschem (India) Ltd SYCH.BO:
APPROVED ISSUE OF SHARES WORTH 319 MILLION RUPEES VIA RIGHTS ISSUE
Source text for Eikon: ID:nBSE6Gqlzd
Further company coverage: SYCH.BO
(([email protected];;))
July 4 (Reuters) - Syschem (India) Ltd SYCH.BO:
APPROVED ISSUE OF SHARES WORTH 319 MILLION RUPEES VIA RIGHTS ISSUE
Source text for Eikon: ID:nBSE6Gqlzd
Further company coverage: SYCH.BO
(([email protected];;))
Syschem (India) To Consider Raising Funds By Way Of Issue Of Fresh Shares Via Right Issue Basis
June 29 (Reuters) - Syschem (India) Ltd SYCH.BO:
TO CONSIDER RAISING FUNDS BY WAY OF ISSUE OF FRESH SHARES VIA RIGHT ISSUE BASIS
Source text for Eikon: ID:nBSE9gXh6B
Further company coverage: SYCH.BO
(([email protected];;))
June 29 (Reuters) - Syschem (India) Ltd SYCH.BO:
TO CONSIDER RAISING FUNDS BY WAY OF ISSUE OF FRESH SHARES VIA RIGHT ISSUE BASIS
Source text for Eikon: ID:nBSE9gXh6B
Further company coverage: SYCH.BO
(([email protected];;))
Syschem (India) climbs on approving Haryana unit expansion plan
** Shares of Syschem (India) SYCH.BO climb up as much as 7.9% at 41.80 rupees
** SYCH on Tuesday approved expansion plan at Haryana unit
** Expansion for manufacturing of antibiotic drugs Amoxicillin and Cephalexin, SYCH said
** Unit capacity will increase from 720 TPA to 1,380 TPA approx., funds required around 100 mln to 120 mln rupees - co
** Stock trading below 50-, 100- and 200-day exponential moving averages
** Including session's gains, stock down ~12% YTD
(Reporting by Hritam Mukherjee in Bengaluru)
(([email protected];))
** Shares of Syschem (India) SYCH.BO climb up as much as 7.9% at 41.80 rupees
** SYCH on Tuesday approved expansion plan at Haryana unit
** Expansion for manufacturing of antibiotic drugs Amoxicillin and Cephalexin, SYCH said
** Unit capacity will increase from 720 TPA to 1,380 TPA approx., funds required around 100 mln to 120 mln rupees - co
** Stock trading below 50-, 100- and 200-day exponential moving averages
** Including session's gains, stock down ~12% YTD
(Reporting by Hritam Mukherjee in Bengaluru)
(([email protected];))
Syschem (India) Approved Plan For Expansion Of Existing Facilities For Manufacturing Of Amoxicillin And Cephalexin At Haryana Unit
June 20 (Reuters) - Syschem (India) Ltd SYCH.BO:
APPROVED PLAN FOR EXPANSION OF EXISTING FACILITIES FOR MANUFACTURING OF AMOXICILLIN AND CEPHALEXIN AT HARYANA UNIT
TOTAL FUND REQUIRED TOWARDS COMPLETION OF PROJECTS AT AROUND 100 MILLION RUPEES TO 120 MILLION RUPEES
Source text for Eikon: ID:nBSE7VYdCH
Further company coverage: SYCH.BO
(([email protected];))
June 20 (Reuters) - Syschem (India) Ltd SYCH.BO:
APPROVED PLAN FOR EXPANSION OF EXISTING FACILITIES FOR MANUFACTURING OF AMOXICILLIN AND CEPHALEXIN AT HARYANA UNIT
TOTAL FUND REQUIRED TOWARDS COMPLETION OF PROJECTS AT AROUND 100 MILLION RUPEES TO 120 MILLION RUPEES
Source text for Eikon: ID:nBSE7VYdCH
Further company coverage: SYCH.BO
(([email protected];))
Syschem (India) March-Quarter Profit Falls
May 15 (Reuters) - Syschem (India) Ltd SYCH.BO:
MARCH-QUARTER PROFIT 3.9 MILLION RUPEES VERSUS PROFIT 24.9 MILLION RUPEES
LTD MARCH-QUARTER TOTAL INCOME FROM OPERATIONS 569.7 MILLION RUPEES VERSUS 225.8 MILLION RUPEES
Source text for Eikon: ID:nBSEf2TfC
Further company coverage: SYCH.BO
(([email protected];;))
May 15 (Reuters) - Syschem (India) Ltd SYCH.BO:
MARCH-QUARTER PROFIT 3.9 MILLION RUPEES VERSUS PROFIT 24.9 MILLION RUPEES
LTD MARCH-QUARTER TOTAL INCOME FROM OPERATIONS 569.7 MILLION RUPEES VERSUS 225.8 MILLION RUPEES
Source text for Eikon: ID:nBSEf2TfC
Further company coverage: SYCH.BO
(([email protected];;))
Events:
Rights
Reverse Split
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Syschem (India) do?
Syschem (India) Ltd specializes in the manufacturing of pesticides including Monocrotophos (MCP) and Dichlorvos (DDVP) in India.
Who are the competitors of Syschem (India)?
Syschem (India) major competitors are Quest Laboratories, Krebs Biochem.&Inds, Panchsheel Organics, Bafna Pharma, IndoAmerican Advance, Kimia Biosciences, Bal Pharma. Market Cap of Syschem (India) is ₹183 Crs. While the median market cap of its peers are ₹180 Crs.
Is Syschem (India) financially stable compared to its competitors?
Syschem (India) seems to be less financially stable compared to its competitors. Altman Z score of Syschem (India) is 2.69 and is ranked 4 out of its 8 competitors.
Does Syschem (India) pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Syschem (India) latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Syschem (India) allocated its funds?
Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable
How strong is Syschem (India) balance sheet?
Balance sheet of Syschem (India) is moderately strong, But short term working capital might become an issue for this company.
Is the profitablity of Syschem (India) improving?
The profit is oscillating. The profit of Syschem (India) is ₹2.76 Crs for Mar 2024, ₹4.51 Crs for Mar 2023 and -₹1.71 Crs for Mar 2022
Is the debt of Syschem (India) increasing or decreasing?
The debt of Syschem (India) is decreasing. Latest debt of Syschem (India) is ₹0.02 Crs as of Sep-24. This is less than Mar-24 when it was ₹0.32 Crs.
Is Syschem (India) stock expensive?
Syschem (India) is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Syschem (India) is 0.0, while 3 year average PE is 39.24. Also latest EV/EBITDA of Syschem (India) is 49.45 while 3yr average is 21.17.
Has the share price of Syschem (India) grown faster than its competition?
Syschem (India) has given better returns compared to its competitors. Syschem (India) has grown at ~21.67% over the last 8yrs while peers have grown at a median rate of 7.0%
Is the promoter bullish about Syschem (India)?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 57.02% and last quarter promoter holding is 53.17%.
Are mutual funds buying/selling Syschem (India)?
There is Insufficient data to gauge this.